Biognosys Partners with Thermo Fisher Scientific
Biognosys has taken a major step forward in proteomics through a new collaboration with Thermo Fisher Scientific. This partnership aims to offer users easy access to Spectronaut software, which is well-known for its impressive capabilities in DIA proteomics analysis.
What is Spectronaut?
Spectronaut is Biognosys' premier software designed for data-independent acquisition mass spectrometry. It leverages advanced algorithms and artificial intelligence to significantly enhance the accuracy and depth of proteomics research, providing crucial insights needed for life sciences investigations.
Details of the Reselling Agreement
This agreement enables Thermo Fisher to directly quote and sell Biognosys' Spectronaut software alongside its mass spectrometry systems. This collaborative effort streamlines the purchasing process for customers, seamlessly integrating the software into Thermo Fisher's existing product lineup.
Benefits of the Agreement
The collaboration adds value to the research community by providing an integrated workflow that merges the expertise of both companies. Users can now access advanced proteomics solutions through a single unified offering, simplifying the execution of data-independent acquisition experiments.
Enhancing Accessibility to Proteomics Solutions
Oliver Rinner, Ph.D., the CEO and founder of Biognosys, shared his enthusiasm about this partnership, highlighting its importance in making Spectronaut software more accessible to researchers. He noted that this collaboration is crucial for improving the generation of comparative results across different mass spectrometry platforms.
Impact of the Partnership on Research
With Thermo Fisher's extensive presence in the scientific community, the availability of Spectronaut will be greatly enhanced, particularly for researchers interested in utilizing advanced proteomics analysis. As it becomes increasingly integrated into Thermo Fisher's offerings, more researchers can take advantage of this cutting-edge technology.
About Biognosys and its Future
The Biognosys team is dedicated to supporting groundbreaking research across the scientific community. As proteomics continues to develop, Biognosys is positioned to lead the way, partnering with companies like Thermo Fisher to drive innovation and elevate research quality.
Frequently Asked Questions
What is the Spectronaut software?
Spectronaut is Biognosys’ flagship software for proteomics data analysis, especially catering to data-independent acquisition mass spectrometry.
What does the partnership with Thermo Fisher involve?
The partnership allows Thermo Fisher to resell Spectronaut software along with their mass spectrometry systems, creating a streamlined offering for customers.
How does Spectronaut improve research outcomes?
It allows for precise quantification of proteins within various biological samples, offering valuable insights into protein functions and structures.
Who is Oliver Rinner?
Oliver Rinner, Ph.D., is the CEO and founder of Biognosys, dedicated to advancing proteomics through innovative software solutions.
What is Biognosys’ mission?
Biognosys strives to empower life science research by providing state-of-the-art proteomics solutions that support better drug development and clinical decision-making.
